subsequent doses should continue as scheduled
Both medications are available, both are effective for weight loss, and both cost dramatically less than in the United States
For now, the research supports continued use as long as results are positive and side effects remain manageable
They may include: nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation (burping), hypoglycemia in patients with diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
Fabricado sin utilizar organismos modificados genticamente (OMG).
The medication belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which mimic a natural hormone regulating appetite and blood sugar levels